Endoplasmic Reticulum Associated Degradation of Spinocerebellar Ataxia-Related CD10 Cysteine Mutant

Int J Mol Sci. 2020 Jun 14;21(12):4237. doi: 10.3390/ijms21124237.

Abstract

Spinocerebellar ataxia (SCA) is one of the most severe neurodegenerative diseases and is often associated with misfolded protein aggregates derived from the genetic mutation of related genes. Recently, mutations in CD10 such as C143Y have been identified as SCA type 43. CD10, also known as neprilysin or neuroendopeptidase, digests functional neuropeptides, such as amyloid beta, in the extracellular region. In this study, we explored the cellular behavior of CD10 C143Y to gain an insight into the functional relationship of the mutation and SCA pathology. We found that wild-type CD10 is expressed on the plasma membrane and exhibits endopeptidase activity in a cultured cell line. CD10 C143Y, however, forms a disulfide bond-mediated oligomer that does not appear by the wild-type CD10. Furthermore, the CD10 C143Y mutant was retained in the endoplasmic reticulum (ER) by the molecular chaperone BiP and was degraded through the ER-associated degradation (ERAD) process, in which representative ERAD factors including EDEM1, SEL1L, and Hrd1 participate in the degradation. Suppression of CD10 C143Y ERAD recovers intracellular transport but not enzymatic activity. Our results indicate that the C143Y mutation in CD10 negatively affects protein maturation and results in ER retention and following ERAD. These findings provide beneficial insight into SCA type 43 pathology.

Keywords: CD10; ER quality control; disulfide bond; endoplasmic reticulum-associated degradation (ERAD); spinocerebellar ataxia.

MeSH terms

  • Cell Membrane / metabolism
  • Cysteine / genetics
  • Disulfides / metabolism
  • Endoplasmic Reticulum / metabolism
  • Endoplasmic Reticulum-Associated Degradation
  • HeLa Cells
  • Humans
  • Mutation*
  • Neprilysin / chemistry*
  • Neprilysin / genetics
  • Neprilysin / metabolism*
  • Oligopeptides / metabolism
  • Proteolysis
  • Spinocerebellar Ataxias / genetics*

Substances

  • Bax-inhibiting peptide, BIP
  • Disulfides
  • Oligopeptides
  • Neprilysin
  • Cysteine